Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare Biotechnology

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

Bullboard Posts

Comment by Chemdogon Jun 14, 2017 5:36pm

105 Views

Post# 26363683

RE:RE:RE:Nearly the whole bulloard post deleted ?

0.14 shares today....
not sure how this can go???
I think 0.14 is the lowest...
I mean shares were 0.11 when this was Santa Maria Petreloum
So not sure who would be selling their 0.11 shares for 0.14
someone who doesn't want to wait....If this hits 0.14 or lower tomoroow
I am buying

smithgee wrote:

Chemdog wrote: yea they finally gave this a proper bull board but in the process deleted the old posts
I missed out on 0.165 today
but if it goes further i will buy more
I have a position now..its RED almost 30% down but I am not worried
this a LONG PLAY

I can't believe management is not stepping in to try and put a floor on the price ... like throw us a bone with some sort of an update to say everything is ok and moving along.